Advised on Sale of CompanyMaterials, Chemicals & Mining
Acquired 100% of Business Operations
SK Capital is a New York-based private equity firm that invests in the specialty materials, chemicals and pharmaceutical sectors. By focusing on niche markets SK Capital leverages its industry expertise to become a value-added partner. The firm currently has more than $1.9 billion under asset management and its portfolio companies generate an estimated $5.0 billion in revenue each year.
The acqusition of Foremark, an industry leader with proprietary, best-in-class production capabilties, is consistent with SK Capital's investment strategy. This strategy involves investing in niche market leaders in segments where the firm has significant industry, operating and ownership experience. According to SK Capital Managing Director Jack Norris,Foremark will be transitioned from a product-oriented company to a leader of intermediates and derivatives for oilfield refineries and petrochemical customers.
Steve Beetham, representing the selling shareholders, commented, “SK Capital is the perfect partner to advance DBWT’s leadership among merchant market producers of formaldehyde and its derivative products."